相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colocalization of Phosphorylated Forms of WAVE1, CRMP2, and Tau in Alzheimer's Disease Model Mice: Involvement of Cdk5 Phosphorylation and the Effect of ATRA Treatment
Naoto Watamura et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2016)
Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer's Disease
Judy C. Triplett et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Alternative functions of the brain transsulfuration pathway represent an underappreciated aspect of brain redox biochemistry with significant potential for therapeutic engagement
Kenneth Hensley et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis
Jeffrey L. Dupree et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD
Antonella Tramutola et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Redox regulation of autophagy in healthy brain and neurodegeneration
Kenneth Hensley et al.
NEUROBIOLOGY OF DISEASE (2015)
A cell-penetrating ester of the neural metabolite lanthionine ketimine stimulates autophagy through the mTORC1 pathway: Evidence for a mechanism of action with pharmacological implications for neurodegenerative pathologies
Marni E. Harris-White et al.
NEUROBIOLOGY OF DISEASE (2015)
Tau stabilizes microtubules by binding at the interface between tubulin heterodimers
Harindranath Kadavath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
What lessons can be learned from failed Alzheimer's disease trials?
Jeremy Toyn
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)
Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP2) and Direct Impairment of its Canonical Function: Implications for the Therapeutic Potential of Lacosamide
Sarah M. Wilson et al.
MOLECULAR NEUROBIOLOGY (2015)
Functional Variants in DPYSL2 Sequence Increase Risk of Schizophrenia and Suggest a Link to mTOR Signaling
Yaping Liu et al.
G3-GENES GENOMES GENETICS (2015)
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
Maria del Carmen Cardenas-Aguayo et al.
ACS CHEMICAL NEUROSCIENCE (2014)
PLXNA4 Is Associated with Alzheimer Disease and Modulates Tau Phosphorylation
Gyungah Jun et al.
ANNALS OF NEUROLOGY (2014)
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Khalid Iqbal et al.
BIOCHEMICAL PHARMACOLOGY (2014)
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
Colin D. Weekes et al.
INVESTIGATIONAL NEW DRUGS (2014)
Semaphorin 3A Signaling Through Neuropilin-1 Is an Early Trigger for Distal Axonopathy in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Kalina Venkova et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature
Antonella Caccamo et al.
JOURNAL OF NEUROSCIENCE (2014)
Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease
Elliott J. Mufson et al.
NEURODEGENERATIVE DISEASES (2014)
Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease
Teng Jiang et al.
PHARMACOLOGICAL RESEARCH (2014)
The functionalized amino acid (S)-Lacosannide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth
Sarah M. Wilson et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification
Devin M. Wolfe et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Diaminothiazoles Modify Tau Phosphorylation and Improve the Tauopathy in Mouse Models
Xuemei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Identification of a Dithiol-disulfide Switch in Collapsin Response Mediator Protein 2 (CRMP2) That Is Toggled in a Model of Neuronal Differentiation
Manuela Gellert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
CRMP2 Protein SUMOylation Modulates NaV1.7 Channel Trafficking
Erik T. Dustrude et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Derivative of the Brain Metabolite Lanthionine Ketimine Improves Cognition and Diminishes Pathology in the 3 x Tg-AD Mouse Model of Alzheimer Disease
Kenneth Hensley et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Lanthionine ketimine ethyl ester partially rescues neurodevelopmental defects in unc-33 (DPYSL2/CRMP2) mutants
Caleb Hubbard et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
Alzheimer disease therapy-moving from amyloid-β to tau
Ezio Giacobini et al.
NATURE REVIEWS NEUROLOGY (2013)
Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system
Laura Caberlotto et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides
Polina Feldman et al.
NEUROSCIENCE LETTERS (2013)
Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs
Leonardo Guzman-Martinez et al.
FRONTIERS IN NEUROLOGY (2013)
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimers diseases
Giovanni Coppola et al.
HUMAN MOLECULAR GENETICS (2012)
A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia
Shadia E. Nada et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
PREVENTION OF POSTTRAUMATIC AXON SPROUTING BY BLOCKING COLLAPSIN RESPONSE MEDIATOR PROTEIN 2-MEDIATED NEURITE OUTGROWTH AND TUBULIN POLYMERIZATION
S. M. Wilson et al.
NEUROSCIENCE (2012)
Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders
Rajesh Khanna et al.
FUTURE NEUROLOGY (2012)
Phenotypic signatures of genetic frontotemporal dementia
Jonathan D. Rohrer et al.
CURRENT OPINION IN NEUROLOGY (2011)
Collapsin Response Mediator Proteins (CRMPs) Are a New Class of Microtubule-associated Protein (MAP) That Selectively Interacts with Assembled Microtubules via a Taxol-sensitive Binding Interaction
Pao-Chun Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Collapsin Response Mediator Protein-2: An Emerging Pathologic Feature and Therapeutic Target for Neurodisease Indications
Kenneth Hensley et al.
MOLECULAR NEUROBIOLOGY (2011)
Autophagy failure in Alzheimer's disease-locating the primary defect
Ralph A. Nixon et al.
NEUROBIOLOGY OF DISEASE (2011)
Thioredoxin Mediates Oxidation-Dependent Phosphorylation of CRMP2 and Growth Cone Collapse
Akifumi Morinaka et al.
SCIENCE SIGNALING (2011)
Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression
Stephen D. Ginsberg et al.
BIOLOGICAL PSYCHIATRY (2010)
Collapsin Response Mediator Protein-2 (Crmp2) Regulates Trafficking by Linking Endocytic Regulatory Proteins to Dynein Motors
Juliati Rahajeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Proteomic Identification of Binding Partners for the Brain Metabolite Lanthionine Ketimine (LK) and Documentation of LK Effects on Microglia and Motoneuron Cell Cultures
Kenneth Hensley et al.
JOURNAL OF NEUROSCIENCE (2010)
Neurotrophic Effects of Tianeptine on Hippocampal Neurons: A Proteomic Approach
Chin-Chen Chu et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Emerging Biological Importance of Central Nervous System Lanthionines
Kenneth Hensley et al.
MOLECULES (2010)
Lacosamide for the prevention of partial onset seizures in epileptic adults
Kelemen et al.
Neuropsychiatric Disease and Treatment (2010)
Synaptic degeneration in Alzheimer's disease
Thomas Arendt
ACTA NEUROPATHOLOGICA (2009)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
Involvement of WAVE Accumulation in Aβ/APP Pathology-Dependent Tangle Modification in Alzheimer's Disease
Kazuyuki Takata et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD
Tanea T. Reed et al.
BRAIN RESEARCH (2009)
Increased CRMP2 Phosphorylation is Observed in Alzheimer's Disease; Does this Tell us Anything About Disease Development?
M. P. M. Soutar et al.
CURRENT ALZHEIMER RESEARCH (2009)
Anterograde Transport of TrkB in Axons Is Mediated by Direct Interaction with Slp1 and Rab27
Nariko Arimura et al.
DEVELOPMENTAL CELL (2009)
An Atypical Role for Collapsin Response Mediator Protein 2 (CRMP-2) in Neurotransmitter Release via Interaction with Presynaptic Voltage-gated Calcium Channels
Joel M. Brittain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
WASP and SCAR/WAVE proteins: the drivers of actin assembly
Alice Y. Pollitt et al.
JOURNAL OF CELL SCIENCE (2009)
Crystal and solution structure, stability and post-translational modifications of collapsin response mediator protein 2
Viivi Majava et al.
FEBS JOURNAL (2008)
Numb Endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner - Implications for Alzheimer disease pathogenesis
George A. Kyriazis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Amyloid Precursor Protein Trafficking, Processing, and Function
Gopal Thinakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The beta-amyloid protein of Alzheimers disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism
Steven Petratos et al.
BRAIN (2008)
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression
Adam R. Cole et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The structure of human collapsin response mediator protein 2, a regulator of axonal growth
Pal Stenmark et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
S. W. Scheff et al.
NEUROLOGY (2007)
The role of neurotrophins in axonal growth, guidance, and regeneration
Maricis G. Lykissas et al.
CURRENT NEUROVASCULAR RESEARCH (2007)
Calpain-mediated collapsin response mediator protein-1,-2, and-4 proteolysis after neurotoxic and traumatic brain injury
Zhiqun Zhang et al.
JOURNAL OF NEUROTRAUMA (2007)
A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord
Shinjiro Kaneko et al.
NATURE MEDICINE (2006)
Protein repair in the brain, proteomic analysis of endogenous substrates for protein L-isoaspartyl methyltransferase in mouse brain
Jeff X. Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level
Amitabha Sengupta et al.
FEBS LETTERS (2006)
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β
T Li et al.
BIOCHEMISTRY (2006)
CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation
Y Kawano et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones
N Arimura et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The generation of a 17 kDa neurotoxic fragment:: An alternative mechanism by which tau mediates β-amyloid-induced neurodegeneration
SY Park et al.
JOURNAL OF NEUROSCIENCE (2005)
Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2:: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease
Y Uchida et al.
GENES TO CELLS (2005)
GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity
T Yoshimura et al.
CELL (2005)
Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons
TT Quach et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
Structural bases for CRMP function in plexin-dependent semaphorin3A signaling
RC Deo et al.
EMBO JOURNAL (2004)
Induction of CRMP-2 by GDNF and analysis of the CRMP-2 promoter region
Y Kodama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons
AR Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease
PF Good et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Identification of Tau and MAP2 as novel substrates of Rho-kinase and myosin phosphatase
M Amano et al.
JOURNAL OF NEUROCHEMISTRY (2003)
In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin
K Kikuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth
T Nishimura et al.
NATURE CELL BIOLOGY (2003)
The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia
K Nakata et al.
BIOLOGICAL PSYCHIATRY (2003)
CRMP-2 induces axons in cultured hippocampal neurons
N Inagaki et al.
NATURE NEUROSCIENCE (2001)
Phosphorylation of collapsin response mediator protein-2 by Rho-kinase -: Evidence for two separate signaling pathways for growth cone collapse
N Arimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522
YJ Gu et al.
BIOCHEMISTRY (2000)
分享论文
